Mo Han Lian
Eclipta prostrata
Also known as: False Daisy(English) Trailing Eclipta(English) Bhringraj(Hindi) Mo Han Lian(Chinese (Pinyin)) 墨旱莲(Chinese)
Cỏ nhọ nồi(Vietnamese vernacular name (not Sino-Vietnamese)) Mo Han Lien
Updated October 5, 2026 · Not yet clinically reviewed
Safety at a glance
5 recorded drug interactions, 1 major or contraindicated
Contraindications or side effects are listed
No toxicity grade is recorded. Most herbs in the catalogue carry none.
Traditional Chinese Medicine
- Category
- tonifying
- Temperature
- Cold
- Taste
- Sweet,Sour
- Channels
- Liver,Kidney
Functions
Nourishes Liver and Kidney Yin; Cools the Blood and stops bleeding; Darkens the hair and strengthens the teeth; Clears Heat from the Blood Level
Traditional uses
Mo Han Lian (eclipta herb, false daisy) is a cool, sweet-sour herb used to nourish Liver and Kidney Yin and cool the Blood to stop bleeding. It is applied for patterns of Liver-Kidney Yin deficiency with premature greying, tinnitus, dizziness, and lower back weakness, and its Blood-cooling properties make it valuable for bleeding conditions from Heat in the Blood — including nosebleeds, hematemesis, and uterine hemorrhage. It is commonly combined with Nu Zhen Zi (ligustrum) in classical Yin-nourishing formulas.
Western herbalism
Properties: hepatic, anti-inflammatory, antioxidant, tonic, astringent
Pharmacological effects
- Immunologic: Decoction increased thymus weight, peripheral leukocytes and carbon clearance in mice.
- Antihepatotoxic: Aqueous extract 300 mg/kg i.p. inhibited serum transaminase rise and histological damage from CCl4 (mice) and GalN (rats); no significant effect on acetaminophen injury.
- Antivenom: Ethanolic extract premixed with Crotalus durissus terrificus venom neutralized up to four lethal doses in mice; wedelolactone, sitosterol and stigmasterol neutralized three; aqueous extract reduced venom myotoxicity.
- Other: Sedative and analgesic effects in mice; powdered herb hemostatic.
Source: Zhu YP. Chinese Materia Medica: Chemistry, Pharmacology and Applications. Harwood Academic, 1998, p. 646.
Formulas using this herb
7 of 7 formulas
- Jia Wei Zuo Gui Wan 加味左归丸
- Ning Xue Tang 宁血汤 · 30.00000g
- Qing Re Liang Xue Tang 清热凉血汤
- San Jia An Shen Wan 三甲安神丸
- Sheng Pu Huang Tang · 24.00000g
- Shou Wu Pian 首乌片
- Wu Zi Tang 五子汤 · 9.00000g
Botanical
Eclipta prostrata is an annual herb in the daisy family (Asteraceae), growing 10-60 cm tall, erect or spreading. Stems are stiff, cylindrical, and covered in rough hairs. Leaves are opposite, sessile, lanceolate to elliptic, 2-8 cm long, with rough surfaces and entire or slightly toothed margins. The small white flower heads are borne on long peduncles in the leaf axils. Florets include both ray and disc florets. When stems or leaves are broken, a black juice is produced that turns dark on exposure to air (characteristic of this species).
- Family
- Asteraceae
- Pharmaceutical name
- Herba Ecliptae
- Parts used
- whole_plant, leaf, stem
- Plant type
- herb
- Native region
- Alabama, Argentina Northeast, Argentina Northwest, Arizona, Arkansas, Bahamas, Belize, Bolivia, Brazil North, Brazil Northeast, Brazil South, Brazil Southeast, Brazil West-Central, California, Chile Central, Chile North, Chile South, Colombia, Connecticut, Costa Rica, Cuba, Delaware, District of Columbia, Dominican Republic, Ecuador, El Salvador, Florida, French Guiana, Georgia, Guatemala, Guyana, Haiti, Honduras, Illinois, Indiana, Iowa, Kansas, Kentucky, Louisiana, Maryland, Masachusettes, Mexico Central, Mexico Gulf, Mexico Northeast, Mexico Northwest, Mexico Southeast, Mexico Southwest, Michigan, Minnesota, Mississippi, Missouri, Nebraska, New Jersey, New Mexico, New York, Nicaragua, North Carolina, Ohio, Oklahoma, Ontario, Panamá, Paraguay, Pennsylvania, Peru, Puerto Rico, Rhode I., South Carolina, South Dakota, Suriname, Tennessee, Texas, Trinidad-Tobago, Uruguay, Venezuela, Vermont, Virginia, West Virginia, Wisconsin
- Conservation status
- least_concern
Habitat
Conservation notes
Eclipta prostrata is an extremely common pantropical weed. It is found on all tropical continents and many subtropical regions. No conservation concerns.
Constituents
Wedelolactone
Coumestan · the Chinese Pharmacopoeia marker; not less than 0.04% of the dried aerial parts by HPLC
The principal marker and the compound most of the pharmacology rests on. It is a direct inhibitor of IKK-beta, so it blocks NF-kB-driven transcription, and it has since been shown to inhibit soluble epoxide hydrolase. In animal work it is hepatoprotective in cholestatic injury, promotes osteoblast differentiation while suppressing osteoclastogenesis, and neutralises the phospholipase A2 and myotoxic activities of animal venoms.
Demethylwedelolactone
Coumestan
The demethylated congener of wedelolactone, consistently co-occurring with it in the aerial parts and used alongside it as a quality marker. It shares the antihepatotoxic and venom-antagonising activity of the coumestan class, and its glucoside is also reported from the plant.
Eclalbasaponins and ecliptasaponins (including ecliptasaponin II)
Oleanane-type triterpenoid saponins
The dominant saponin series of the herb. Ecliptasaponin II has been shown to activate PPAR-gamma and thereby reduce endothelial apoptosis in a radiation enteritis model, which is the best-characterised single activity in this group. The saponins as a class also account for much of the herb's surface activity and its irritant potential at high oral doses.
Sulfated flavonoids (flavone sulfate conjugates)
Flavonoid sulfate esters
An unusual feature of this species: a family of sulfate-conjugated flavonoids that a 2024 LC-MS survey proposed as additional quality-evaluation markers, because their pattern separates authentic Eclipta prostrata material more sharply than wedelolactone content alone.
Luteolin and luteolin-7-O-glucoside
Flavone and flavone glycoside
Common flavonoid constituents of the aerial parts, contributing antioxidant and anti-inflammatory activity in extract-level assays. They are not species-specific and should not be used to authenticate the drug.
Thiophene and bithiophene derivatives
Polyacetylene-derived thiophenes
A small series of sulfur heterocycles, several of them new compounds described from this species, with reported antibacterial activity in vitro. Their presence is chemotaxonomically consistent with the Asteraceae.
Triterpenoids and sterols (including beta-amyrin and echinocystic acid derivatives)
Triterpenoids and phytosterols
Bulk lipophilic constituents of the aerial parts. A 2020 phytochemical study isolated a further set of bioactive terpenoids from the species, so the terpenoid fraction is chemically richer than older monographs suggest.
Drug interactions
Warfarin and other vitamin K antagonist anticoagulants
Theoretical · Unpredictable change in INR in either direction · Evidence level: Theoretical
There is no human pharmacokinetic study of Eclipta prostrata with any anticoagulant, and this entry should be read as a caution rather than a finding. The concern is structural and pharmacological rather than observed: the coumestans are benzofuran-fused coumarins, and the herb's own traditional indication is bleeding, so both directions of effect are conceivable. Nothing in the published literature quantifies either.
Clinical note: Do not assume a direction of effect. If a patient on warfarin takes this herb, check INR within one to two weeks of starting or stopping it.
Ciclosporin, tacrolimus and other immunosuppressants
Theoretical · Possible additive suppression of NF-kB-dependent immune signalling · Evidence level: Theoretical
Wedelolactone is a well-characterised direct IKK-beta inhibitor and therefore blocks NF-kB activation, and it has separately been shown to inactivate macrophages by targeting soluble epoxide hydrolase. Both are immunosuppressive mechanisms demonstrated in vitro and in rodents. Whether oral doses of the crude herb reach the plasma concentrations used in those experiments has not been measured, so additivity in a transplant or autoimmune patient is inferred, not shown.
Clinical note: Reasonable to avoid in transplant recipients and in patients on biologic or calcineurin-inhibitor therapy, on the grounds that the interaction is unstudied rather than excluded.
Tamoxifen, aromatase inhibitors and hormone replacement therapy
Theoretical · Possible interference with oestrogen-directed therapy · Evidence level: Possible
Coumestans are the classical phytoestrogen scaffold, and the herb behaves like a mild oestrogenic agent in the model where that would matter most: an aqueous Ecliptae herba extract improved bone metabolism in ovariectomised rats, and wedelolactone shifts the osteoblast-osteoclast balance through Wnt/beta-catenin and NF-kB. Receptor-binding data for the specific constituents of this species are thin, so the class inference is stronger than the species evidence.
Clinical note: Avoid in patients on endocrine therapy for hormone-receptor-positive breast cancer until receptor-level data exist.
Antivenom serum in snake or hymenoptera envenomation
Major · Delayed definitive treatment if the herb is used in place of antivenom; envenomation can be fatal · Evidence level: Established
Eclipta prostrata is a genuinely active antivenom plant: the extract and isolated wedelolactone antagonise phospholipase A2, myotoxic and haemorrhagic activities of snake venoms, and a 2026 study extended this to Apis mellifera venom. That real activity is the hazard. It is measured in vitro and in rodents at applied doses, has never been shown to clear systemic envenomation in a human, and its reputation in folk practice invites substitution for hospital antivenom.
Clinical note: Never a substitute for antivenom or for emergency care. Envenomation is a hospital problem; the herb has no established role in it.
Oral hypoglycaemic agents and insulin
Theoretical · Possible additive lowering of blood glucose · Evidence level: Theoretical
Antidiabetic activity of Eclipta extracts and of its saponin fraction is reported repeatedly in rodent and enzyme-inhibition models and is summarised in the current reviews of the species. No human glucose data exist, so the additive risk with a hypoglycaemic drug is extrapolated from animal work.
Clinical note: If used in a diabetic patient, ask them to monitor capillary glucose more closely for the first two weeks.
Dosage
| Form | Amount | Frequency | Population | Notes |
|---|---|---|---|---|
| decoction | 6–12 g | daily | adult | 中国药典 2020年版 一部 【墨旱莲】【用法与用量】6~12g。 — Chinese Pharmacopoeia 2020, Vol. I. |
Evidence
Study design on record, not certainty of outcome.
- In vitro / animal
- 7
Therapeutic effect of aqueous extract from Ecliptae herba on bone metabolism of ovariectomized rats
Zhang ZG, Bai D, Liu MJ, Li Y, Pan JH, Liu H, Wang WL, Xiang LH, Xiao GG, Ju DH · Menopause · 2013 · animal
In vitro / animal · Not yet verified
Aqueous Ecliptae herba extract given to ovariectomised rats improved bone metabolic parameters relative to untreated ovariectomised controls, supporting the traditional use for weakened teeth and lumbar soreness in Liver-Kidney yin deficiency. This is a rodent oestrogen-deficiency model, not a study in postmenopausal women, and no fracture or bone mineral density endpoint in humans has been reported for the herb.
Wedelolactone enhances osteoblastogenesis by regulating Wnt/β-catenin signaling pathway but suppresses osteoclastogenesis by NF-κB/c-fos/NFATc1 pathway
Liu YQ, Hong ZL, Zhan LB, Chu HY, Zhang XZ, Li GH · Scientific Reports · 2016 · in vitro
In vitro / animal · Verified
Wedelolactone acted on both arms of bone remodelling in cell culture: it promoted osteoblast differentiation through Wnt/beta-catenin and suppressed osteoclast formation through NF-kB, c-fos and NFATc1. This gives the ovariectomised-rat result a plausible molecular basis at the level of the isolated marker compound rather than the crude herb.
Wedelolactone alleviates cholestatic liver injury by regulating FXR-bile acid-NF-κB/NRF2 axis to reduce bile acid accumulation and its subsequent inflammation and oxidative stress
Wang MQ, Zhang KH, Liu FL, Zhou R, Zeng Y, Chen AL, Yu Y, Xia Q, Zhu CC, Lin CZ · Phytomedicine · 2024 · animal
In vitro / animal · Verified
In a rodent cholestasis model wedelolactone reduced bile acid accumulation and the downstream inflammation and oxidative stress, acting through FXR with NF-kB and NRF2 downstream. It is the most mechanistically complete of the hepatoprotection studies behind the herb's reputation in liver disease, but it is an isolated compound in rodents and does not establish a role in human hepatitis or cholestasis.
Eclipta prostrata extract and wedelolactone antagonize Apis mellifera venom activities
Nogueira-Souza PD, Rocha-Junior JRDS, Romanelli MA, Monteiro-Machado M, Peçanha TSS, de Almeida MM, Patrão-Neto FC, Melo PA · Toxicon · 2026 · animal
In vitro / animal · Verified
Extends the plant's long-documented anti-snake-venom activity to honeybee venom: both the Eclipta prostrata extract and isolated wedelolactone antagonised venom-induced effects in the assays used. Useful confirmation that the antivenom activity is real and attributable partly to the coumestan marker, and useful precisely as a reason not to let the herb substitute for clinical treatment of envenomation.
Eclipta prostrata promotes the induction of anagen, sustains the anagen phase through regulation of FGF-7 and FGF-5
Lee KH, Choi D, Jeong SI, Kim SJ, Lee CH, Seo HS, Jeong HS · Pharmaceutical Biology · 2019 · animal
In vitro / animal · Not yet verified
Topical Eclipta prostrata extract induced and prolonged the anagen phase of the hair cycle in mice, with FGF-7 upregulated and FGF-5 downregulated. This is the best-characterised experimental support for the classical claim that the herb darkens and strengthens the hair, but it is a mouse model of hair cycling with a topical preparation, not a trial of the oral drug in human alopecia.
Ecliptasaponin II alleviates the radiation enteritis by activating PPARγ to inhibit the apoptosis of endothelial cells
Zeng X, Zhang L, He J, Zhang Y, Lu H, Liu Z, Wang Z, Wei Z · International Immunopharmacology · 2025 · animal
In vitro / animal · Not yet verified
Ecliptasaponin II reduced radiation-induced intestinal injury by activating PPAR-gamma and limiting endothelial apoptosis. This is the clearest activity attributed to a named saponin of the species rather than to the coumestan fraction, and it points at a use the classical literature does not describe.
Effects of Eclipta prostrata on gut microbiota of SAMP6 mice with osteoporosis
Zhao X, Ai J, Mao H, Gao X · Journal of Medical Microbiology · 2019 · animal
In vitro / animal · Verified
Eclipta prostrata altered the gut microbiota of senescence-accelerated SAMP6 mice with osteoporosis, offering a second, microbiota-mediated route by which the herb might affect bone besides the direct osteoblast and oestrogen-like effects. Exploratory rodent work with no human counterpart.
Safety
Contraindications
Its use is prohibited in patients with deficiency- cold of the spleen and kidney.
Source: Xi S, Gong Y. Essentials of Chinese Materia Medica and Medical Formulas. Academic Press/Elsevier, 2017, pp. 368–376.
Cultural and historical
Xin Xiu Ben Cao (Tang Ben Cao) · Tang dynasty, 659 CE
Ben Cao Gang Mu · Ming dynasty, 1596
Yin Pian Xin Can · Republican period, 1936
References
- Feng L, Zhai YY, Xu J, Yao WF, Cao YD, Cheng FF, Bao BH, Zhang L. A review on traditional uses, phytochemistry and pharmacology of Eclipta prostrata (L.) L.. Journal of Ethnopharmacology. 2019 doi:10.1016/j.jep.2019.112109
- Timalsina D, Devkota HP. Eclipta prostrata (L.) L. (Asteraceae): Ethnomedicinal Uses, Chemical Constituents, and Biological Activities. Biomolecules. 2021 doi:10.3390/biom11111738
- Ha NM, Hop NQ, Son NT. Wedelolactone: A molecule of interests. Fitoterapia. 2023 doi:10.1016/j.fitote.2022.105355
- Chung IM, Rajakumar G, Lee JH, Kim SH, Thiruvengadam M. Ethnopharmacological uses, phytochemistry, biological activities, and biotechnological applications of Eclipta prostrata. Applied Microbiology and Biotechnology. 2017 doi:10.1007/s00253-017-8363-9
- Sato R, Nishidono Y, Tanaka K. Comprehensive Analysis of Sulfated Flavonoids in Eclipta prostrata for Quality Evaluation. Molecules. 2024 doi:10.3390/molecules29204888
- Yu SJ, Yu JH, Yu ZP, Yan X, Zhang JS, Sun JY, Zhang H. Bioactive terpenoid constituents from Eclipta prostrata. Phytochemistry. 2020 doi:10.1016/j.phytochem.2019.112192